These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Comparative study of adriamycin and thiotepa in the chemoprophylaxis of superficial bladder tumors]. Salinas Sánchez AS; Moreno Avilés J; Pérez Albacete M; Salmerón Lopez-Rua J; Guardiola Más A; Server Falgas G Actas Urol Esp; 1989; 13(2):99-102. PubMed ID: 2499166 [TBL] [Abstract][Full Text] [Related]
30. Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. Veenema RJ; Dean AL; Uson AC; Roberts M; Longo F J Urol; 1969 May; 101(5):711-5. PubMed ID: 4976352 [No Abstract] [Full Text] [Related]
31. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder]. Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914 [No Abstract] [Full Text] [Related]
33. The prophylaxis of nonindustrial urothelial tumours. Mount BM Can Med Assoc J; 1973 Jun; 108(12):1531-2 passim. PubMed ID: 4197537 [TBL] [Abstract][Full Text] [Related]
34. [Recurrence prevention of papillomas of the bladder using lycurim instillation]. Zárandy B; Szabó J; Molnár I; Sallai Z; Simon Z; Légrády J Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094 [TBL] [Abstract][Full Text] [Related]
35. The effect of intravesical thiotepa on the recurrence rate of newly diagnosed superficial bladder cancer. An MRC Study. MRC Working Party on Urological Cancer. Br J Urol; 1985 Dec; 57(6):680-5. PubMed ID: 2867800 [TBL] [Abstract][Full Text] [Related]
36. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa]. Martínez-Piñeiro JA; de la Peña J; Hidalgo L; Cisneros J; Jiménez León J; Machuca J; Perdices C Arch Esp Urol; 1985; 38(6):545-53. PubMed ID: 3938633 [No Abstract] [Full Text] [Related]
37. [Fatal bone marrow aplasia due to endovesical thio-tepa]. Navas P; Grasset D J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):489-91. PubMed ID: 4216649 [No Abstract] [Full Text] [Related]
38. [Prevention of postoperative recurrence of bladder cancer: a clinical study]. Yang D; Li S; Wang H; Li X; Liu S; Han W; Hao J; Zhang H Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):464-5. PubMed ID: 11829890 [TBL] [Abstract][Full Text] [Related]
39. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma]. Zhang SX; Deng XZ; Tang XD Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180 [No Abstract] [Full Text] [Related]
40. [Chemoprophylaxis with intravesical thiotepa in non-infiltrating bladder tumors]. Lancina Martín J; Monsalve Rodríguez M; Gómez Cisneros S; García Alonso J Arch Esp Urol; 1986 Sep; 39(7):479-83. PubMed ID: 3099658 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]